Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases
Work
Year: 2023
Type: article
Abstract: Importance Use of tyrosine kinase inhibitors (TKIs) is the standard therapy for epidermal growth factor receptor ( EGFR )–mutated non–small cell lung cancer (NSCLC) with brain metastases. Several stud... more
Source: JAMA Network Open
Institutions Sun Yat-sen University, Sun Yat-sen University Cancer Center, Meizhou City People's Hospital, First People's Hospital of Foshan, Southern Medical University +6 more
Cites: 39
Cited by: 26
Related to: 10
FWCI: 11.34
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,000